Clinical Trial Update: IQP-CL-101 in IBS Management [Phase 3]

View source ↗

Summary

Phase 3 clinical trial IQP-CL-101 for Irritable Bowel Syndrome has completed. The update notes the trial status as completed; no efficacy results are provided i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• IQP-CL-101

Snippet

Sponsor: InQpharm Group | Conditions: Irritable Bowel Syndrome | Phase 3 | Status: COMPLETED